Crohn's Disease and Colitis Trial, Recruiting (NCT04178408)

Crohn's Disease and Colitis Trial, Recruiting NCT04178408 Sponsor: University of Zimbabwe Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT04178408 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

As a Case (person with IBD):

People who have been diagnosed with confirmed inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis
People whose IBD symptoms started at least 3 months ago

As a Control (comparison participant):

People aged 18 or older who are a sibling, cousin, or neighbour of someone with IBD (note: people with IBD who are under 18 will not be included in the case-control part of the study)
One sibling or cousin, and one neighbour, per person with IBD are needed as controls

Who may not be able to join:

Controls only (there are no exclusions listed for cases):

People who are suspected of having inflammatory bowel disease
People who have unexplained gut symptoms, including diarrhoea, vomiting, ongoing stomach pain, unexplained weight loss, blood in the stool, or a recent change in bowel habits
People who have had gut surgery where the reason was never fully explained

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Leolin Katsidzira, MD, University of Zimbabwe

Phone: +263 77 2377 416

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04178408

Sponsor: University of Zimbabwe

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +263 77 2377 416

More information: https://clinicaltrials.gov/study/NCT04178408

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

As a Case (person with IBD):

People who have been diagnosed with confirmed inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis
People whose IBD symptoms started at least 3 months ago

As a Control (comparison participant):

People aged 18 or older who are a sibling, cousin, or neighbour of someone with IBD (note: people with IBD who are under 18 will not be included in the case-control part of the study)
One sibling or cousin, and one neighbour, per person with IBD are needed as controls

Who may not be able to join:

Controls only (there are no exclusions listed for cases):

People who are suspected of having inflammatory bowel disease
People who have unexplained gut symptoms, including diarrhoea, vomiting, ongoing stomach pain, unexplained weight loss, blood in the stool, or a recent change in bowel habits
People who have had gut surgery where the reason was never fully explained

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Zimbabwe

Registry

ClinicalTrials.gov

Start date

2 January 2021

Est. completion

31 December 2025

Where this trial is recruiting

Zimbabwe

Primary endpoints

Demographic and phenotypic features of inflammatory bowel disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov